-
Recent Posts
- Investors Encouraged by Preliminary Results of Drug Study from MediciNova, Inc. (NASDAQ: MNOV)
- Can Axiologix, Inc. (PINKSHEETS: AXLX) Turn Definitive Agreement into an Actual Acquisition?
- Gevo, Inc. (NASDAQ: GEVO) Gets Big Boost Following Resumption of Isobutanol Production
- Will Generex Biotechnology Corp. (OTCQB: GNBT) Advance Breast Cancer Treatment to the Next Stage?
- Amicus Therapeutics, Inc. (NASDAQ: FOLD) Taking a Hit Following FDA Decision
Categories
OTC Equity Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods china cloud computing copper drilling energy energy stocks exploration facebook fda gas gold gold mining google healthcare healthcare stocks investors ipad iphone medical marijuana mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks pharmaceutical pinksheets Pink Sheets s silver sprint stocksSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: cardium therapeutics
Can Cardium Therapeutics (AMEX: CXM) Capitalize on FDA Approval and Commercialization Deal During First Quarter 2012?
Shareholders of Cardium Therapeutics (AMEX: CXM) have endured a lot over the years, waiting patiently for the day when the biotechnology company would gain FDA approval for a product and begin generating meaningful revenue. In October 2011 CXM received that … Continue reading
Posted in AMEX, Articles, Penny Stocks
Tagged biotechnology, cardium therapeutics, cxm, diabetes, fda, investors, penny stocks, pharmaceutical, wound care
Leave a comment
Cardium Therapeutics, Inc. Remains in Limbo as FDA Approval for Excellagen Remains Questionable
It has been nearly a year since Cardium Therapeutics, Inc. (AMEX: CXM) submitted their FDA 501(k) application for approval to market and sell their wound care management topical gel product Excellagen and investors are getting antsy as the delay continues … Continue reading
Posted in AMEX, Articles
Tagged amex, cardium therapeutics, cxm, diabetes, diabetic foot ulcers, excellagen, fda, genrx, investors, penny stocks, wound care management
Leave a comment


